Drug recall · August 8, 2012
Xactdose Phenytoin Oral Suspension recall
Why: Defective container; lidding deformity allows the contained product to transpire causing potential viscosity and assay failures. The viscosity and assay failures were due to the loss of moisture. The loss of moisture caused the viscosity to increase and assay to increase relative to the sample volume.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Xactdose Phenytoin Oral Suspension, USP 125 mg/5mL, supplied in 5 mL unit dose cups, VISTAPHARM, Largo, FL NDC 66689-036-50
- Lots / codes
Lot #'s 210900, 214000, 220100, 224800, 228700, 232800
- Quantity
- 27,221 unit dose cups
- Company
- VistaPharm, Inc., Largo, FL
- Distribution
- Nationwide
- Initiated
- September 30, 2011 · Voluntary: Firm initiated
- Classified
- August 2, 2012
- Reported
- August 8, 2012
- Ended
- December 12, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Phenytoin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.